Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Exela Pharma Sciences LLC recalls 8.4% Sodium Bicarbonate Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • 8.4% Sodium Bicarbonate Injection
Where it was sold

Nationwide

Nationwide

Units affected
103,950 vials
About this recall
8.4% Sodium Bicarbonate Injection, USP, 50 mEq/50 mL (1 mEq/mL), 25 x 50 mL Single Dose Vials per carton, For Intravenous Use Only, Rx Only, Manufactured by: Exela Pharma Sciences, LLC, Lenoir, NC 28645. NDC Inner Vial: 51754-5001-1; NDC Carton: 51754-5001-4